Holdings of the Fund as of 11/22/2024
Total Number of Holdings (excluding cash): 49
| Masimo Corporation |
MASI |
574795100 |
478 |
$82,674.88 |
2.61% |
| Penumbra, Inc. |
PEN |
70975L107 |
331 |
$81,042.04 |
2.56% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
953 |
$80,738.16 |
2.55% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
139 |
$76,153.93 |
2.41% |
| Insulet Corporation |
PODD |
45784P101 |
289 |
$75,986.77 |
2.40% |
| Stryker Corporation |
SYK |
863667101 |
189 |
$72,736.65 |
2.30% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
228 |
$72,182.52 |
2.28% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
650 |
$71,643.00 |
2.26% |
| DexCom, Inc. |
DXCM |
252131107 |
972 |
$70,790.76 |
2.24% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,434 |
$70,466.51 |
2.23% |
| Waters Corporation |
WAT |
941848103 |
188 |
$70,212.36 |
2.22% |
| Boston Scientific Corporation |
BSX |
101137107 |
772 |
$69,480.00 |
2.20% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
987 |
$69,563.76 |
2.20% |
| Align Technology, Inc. |
ALGN |
016255101 |
303 |
$68,444.67 |
2.16% |
| ResMed Inc. |
RMD |
761152107 |
280 |
$68,258.40 |
2.16% |
| Abbott Laboratories |
ABT |
002824100 |
579 |
$68,183.04 |
2.15% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,965 |
$66,654.70 |
2.11% |
| Terumo Corporation |
4543.JP |
J83173104 |
3,360 |
$66,690.97 |
2.11% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
200 |
$66,582.00 |
2.10% |
| Hologic, Inc. |
HOLX |
436440101 |
843 |
$66,571.71 |
2.10% |
| Cochlear Limited |
COH.AU |
Q25953102 |
341 |
$66,097.59 |
2.09% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
521 |
$64,868.37 |
2.05% |
| Medtronic Plc |
MDT |
G5960L103 |
753 |
$64,916.13 |
2.05% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,736 |
$64,533.18 |
2.04% |
| Becton, Dickinson and Company |
BDX |
075887109 |
284 |
$63,616.00 |
2.01% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
182 |
$63,515.81 |
2.01% |
| Steris Plc |
STE |
G8473T100 |
296 |
$63,444.64 |
2.01% |
| The Cooper Companies, Inc. |
COO |
216648501 |
630 |
$63,504.00 |
2.01% |
| Agilent Technologies, Inc. |
A |
00846U101 |
468 |
$62,637.12 |
1.98% |
| Revvity, Inc. |
RVTY |
714046109 |
554 |
$62,064.62 |
1.96% |
| Hoya Corporation |
7741.JP |
J22848105 |
494 |
$61,820.69 |
1.95% |
| Baxter International Inc. |
BAX |
071813109 |
1,841 |
$61,139.61 |
1.93% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
739 |
$60,923.16 |
1.93% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,166 |
$60,479.31 |
1.91% |
| Alcon Inc. |
ALC.SW |
H01301128 |
696 |
$59,677.16 |
1.89% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
327 |
$59,602.52 |
1.88% |
| Danaher Corporation |
DHR |
235851102 |
249 |
$58,724.16 |
1.86% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,734 |
$58,545.37 |
1.85% |
| BioMerieux |
BIM.FP |
F1149Y232 |
564 |
$57,979.59 |
1.83% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
113 |
$57,998.38 |
1.83% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,540 |
$56,213.27 |
1.78% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
46 |
$56,026.62 |
1.77% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,092 |
$54,952.27 |
1.74% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
441 |
$54,983.24 |
1.74% |
| Teleflex Incorporated |
TFX |
879369106 |
285 |
$54,637.35 |
1.73% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
9,278 |
$54,886.92 |
1.73% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,243 |
$54,293.05 |
1.72% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
926 |
$53,480.00 |
1.69% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
948 |
$50,158.68 |
1.59% |
| US Dollar |
$USD |
|
2,598 |
$2,598.06 |
0.08% |
| Japanese Yen |
$JPY |
|
118,638 |
$766.15 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.05 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.09 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|